Product category:
Plant Design and Construction
News Release from: NNE (Novo Nordisk Engineering)
Edited by the Processingtalk Editorial
Team on 05 March 2004
Insulin purification facility well under
way
The largest ongoing project at NNE is the establishment of an insulin purification facility, PIA II, being built for Novo Nordisk A/S in Kalundborg, alongside the sister factory opened in 2001
The largest ongoing project at NNE is the planning and establishment of an insulin purification facility Being built for Novo Nordisk A/S in Kalundborg, the new facility will be called PIA II and is a sister factory for PIA I, which NNE handed over to Novo Nordisk in 2001
This article was originally published on Processingtalk on 1 Sep 2003 at 8.00am (UK)
Related stories
Modular system for Fast-track Pharma projects
"Time is of the essence" in establishing new biotech or pharma production: NNE has developed a "Modular" approach to plant construction, that has been shown to reduce overall construction timescales
Inaugural facility of the year award
Sponsored by ISPE, Interphex, and Pharmaceutical Processing Magazine Novo Nordisk was awarded the first Facility of the Year during the Interphex 2005 Conference and Exhibition
The factory is being built as a fast-track project using Modular Engineering to reduce construction time to 18 months, calculated from the granting of initial funding to final qualification and hand-over to the client.
The first sod for PIA II was cut on 26 June 2003, and the topping-out ceremony was held on 27 February 2004.
In parallel with construction work, production plant is being produced and assembled in prefabricated units.
These units will be transported to the building site and put in place in the building one by one.
The next steps will then be establishing connections to and between the units, installing and testing a management system, and completing the building before conducting final tests and handing over the factory to the client.
In addition to the building and production plant, the project encompasses various auxiliary equipment, offices and process control laboratories.
About 200 NNE employees are involved in building the factory covering well over 7,000 m2.
With a very few minor exceptions, work has progressed according to the time frame.
Even the smallest delays are quickly identified and compensated for, a pre-requisite for smooth completion of the next project phase, when activities will be concentrated on the building site, and interdependencies between the numerous parallel processes really become a crucial factor for project management.
The project represents an investment of approx DKK 800 million for Novo Nordisk A/S.
• NNE (Novo Nordisk Engineering): contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
Search the Pro-Talk network of sites
